July - 2017

Biosimilars are coming to Oncology

How will biosimilars impact the oncology market in the US? Will physician's adopt them quickly or will they need more real world evidence...

From STAT: One big cancer breakthrough is likely on the way to patients. Here’s what may be coming n

Medscape Hospitalist Compensation Report 2017

Are you earning more or less than your hospitalist peers? Find out how many hours hospitalists work, how much time they spend with...

I-O Market Heats Up the Summer of 2017: Merck gaining on BMS Share

The fast passed I-O market continues to heat up. New June market share data from Symphony Health shows Keytruda gaining 4 percentage...

Oncology leads the way in drug development across all therapeutic areas

PhRMA released its "Pharmaceutical Pipeline Report" today. Not too surprising to see all the activity in oncology. But almost a third of...

Women often encountered the "broken rung" along their career journey. What is your experie

Women often encountered the "broken rung" along their career journey. What is your experience?

More I-O targets mean more shots on goal.

New Report Available from ACS: Progress in Global Cancer Fight is not only Possible, but Achievable

Breast Cancer Awareness Month begins today and I honor you!

Great progress in cancer drug development and approvals but still incredible unmet need.

How long should an office visit be? Is 20 minutes enough? Can you call that patient-centric care?

Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit

Top 20 Drugs of 2018 from Fierce Pharma

IQVIA report outlines key 2018 approvals and more